Skip to main content

Cellexus Lands Canadian Distributor

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – UK-based bioreactor maker Cellexus said today that it has signed up Vancouver-based life and analytical sciences company Discovery Scientific to distribute its products in Canada.

Cellexus supplies the CellMaker line of single-use disposable bioreactors for use in cell culture and fermentation bioprocesses.

Cellexus of Huntington, UK, said that the distribution agreement is part of an expansion strategy to drive up sales in key regions.

“Selling into Canada presents unique challenges so it makes good business sense for use to work with Discovery Scientific, with the local knowledge and expertise as well as an established client base, to drive sales in this geography,” Cellexus’ Chief Operating Office Paul Stubbings added.

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.